Telit Cinterion to Onshore its Trusted Manufacturing to the United States

The largest western IoT player to onshore manufacturing of cellular modules and products in the U.S. with production starting in October 2026

• Pennsylvania facility: New manufacturing facility in the heart of the nation’s largest defense industrial complex establishes domestic production capacity to support critical infrastructure customers, advances America’s technology manufacturing base, and creates local jobs.
• Location is key: Pennsylvania supports Telit Cinterion’s position as the leading IoT module vendor to critical national infrastructure, defense and mission critical applications globally.
• First in industry: Telit Cinterion is bringing its pioneering trusted and secure technology, developed over 30 years in the U.S. and allied nations, to be manufactured domestically.

BOCA RATON, Fla., Sept. 2, 2026 /PRNewswire/ — Telit Cinterion, a global Internet of Things (IoT) enabler, today announced that it is expanding its global manufacturing apparatus by adding operations in the United States. From the new facility in Bristol, Pennsylvania, starting in October 2026, Telit Cinterion will serve the American and global markets with cellular 4G and 5G IoT modules, and OEM customer products such as routers and gateways.

The 8,000 square-foot facility will house manufacturing, testing, and quality assurance. Support functions including engineering and supply chain will be supported by the company’s existing offices in Research Triangle Park, North Carolina, and Boca Raton, Florida. The first phase of the initiative is expected to create at least 50 high-value jobs.

The start of U.S. production marks the first phase of Telit Cinterion’s long-term commitment to expanding domestic capabilities. The new operation establishes a foundation for continued investment in U.S. manufacturing, workforce development, and supply chain resiliency.

“The Bristol facility represents an important step in strengthening trusted technology supply chains and increasing domestic manufacturing capacity for IoT connected devices and AI-enabled solutions,” said Paolo Dal Pino, Telit Cinterion CEO. “It on shores our trusted manufacturing capability designed to provide U.S. and global customers with, greater traceability, quality assurance, operational resilience, and greater supply chain transparency that aligns with new regulations in the U.S. and western countries.”
 

More information about Telit Cinterion U.S. manufacturing may be found here. 

About Telit Cinterion

Telit Cinterion is a global IoT leader with over 30 years of innovation experience. It provides modules, connectivity plans and services, platforms, and secure, scalable custom solutions.

Telit Cinterion’s product portfolio supports mission-critical applications across industries. In addition, it simplifies lifecycle management and device-to-cloud security. The company helps enterprises connect, manage and grow their IoT systems with confidence.

OEMs, system integrators and service providers worldwide trust Telit Cinterion. The company drives digital transformation and unlocks the power of connected technology.

For more information, follow us on YouTube, X, LinkedIn and Facebook. Visit telit.com or subscribe to receive our marketing communications.

Copyright © 2026 Telit IoT Solutions Holding Ltd. and/or its affiliated companies. All rights reserved. Telit Cinterion, Telit, OneEdge, Cinterion, and all associated logos are trademarks and/or registered trademarks of Telit Communications S.p.A, Telit Communications LTD, Telit IoT Solutions Holding Ltd. and/or their affiliated companies in the United States and/or other countries. Other names used herein may be trademarks of their respective owners.

Media Contacts

Greg Oppenheim
Telit Cinterion
+1 949-540-1278
[email protected]

Casey Bush
GRC for Telit Cinterion
[email protected]

SOURCE Telit Cinterion

Source link

Shionogi gains $36.9 million U.S. order for Fetroja

KEY POINTS

• Shionogi secures $36.9 million after U.S. government exercises cefiderocol procurement option
• BARDA Project BioShield contract includes options for U.S. manufacturing, pathogen-focused development and pediatric label expansion
• Initial funding totals $119 million, with potential contract value rising to $482 million

The BARDA Project BioShield contract also covers U.S. manufacturing, priority-pathogen development and potential pediatric label expansion for cefiderocol. Photo by Pavel Danilyuk on Pexels
Pavel Danilyuk

Shionogi & Co. said on August 28 that the U.S. government had exercised a procurement option for cefiderocol, a treatment for Gram-negative bacterial infections, under a contract through the Biomedical Advanced Research and Development Authority’s Project BioShield program.

The exercised option will bring $36.9 million to the Shionogi group. Cefiderocol is sold in the United States under the brand name Fetroja.

Shionogi signed the contract with the U.S. government on April 8 as part of Project BioShield, a U.S. Department of Health and Human Services program designed to accelerate the research, development, procurement and supply of medical countermeasures against chemical, biological, radiological and nuclear threats.

Under the agreement, Shionogi initially received $119 million in funding. The contract includes multiple related options, including the establishment of a U.S. pharmaceutical manufacturing site for cefiderocol, development targeting infections caused by high-priority pathogens considered biological threats, and a supplemental new drug application to the U.S. Food and Drug Administration to expand the drug’s label for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in pediatric patients.

If those options advance, total funding under the contract could reach as much as $482 million, the company said.

Shionogi said the impact of the procurement option on its consolidated earnings for the fiscal year ending March 2027 would be minimal.

Cefiderocol is marketed in the United States for adult patients with complicated urinary tract infections, including pyelonephritis, caused by certain Gram-negative bacteria, as well as hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. The drug is also sold in multiple markets including Japan, Europe and Taiwan.

Shionogi is also working with the Global Antibiotic Research and Development Partnership and the Clinton Health Access Initiative to prepare for broader patient access to cefiderocol in low- and middle-income countries and upper-middle-income countries, the company said. Antimicrobial resistance is a major public health concern globally, and the company said an estimated 1.14 million people died worldwide in 2021 from AMR.

Source link

ISM Manufacturing PMI August 2026: Expansion Slows Amid Tariff and War Concerns – News and Statistics

Sep 1, 2026

The U.S. manufacturing sector continued its expansion in August, marking the eighth straight month of growth, as the Institute for Supply Management‘s latest Purchasing Managers Index came in at 54.6%—a decline of one full percentage point from July’s figure. ISM also reported that the broader economy has now grown for 22 consecutive months. Any reading below the 50% threshold signals contraction within the industry.

Meanwhile, the S&P Global U.S. Manufacturing PMI held steady at 53.9%, matching its July level. Susan Spence, chair of ISM’s Manufacturing Business Survey Committee, said during a Monday media call that despite the ongoing expansion, the Iran war and tariff threats remain the foremost concerns for the manufacturing sector.

Survey comments in August were split, with 42% positive and 58% negative, translating to a 1-to-1.4 ratio of positive to negative sentiment, according to Spence’s news release. Among the negative remarks, pricing volatility was cited in 57%, extended lead times in 46%, the Iran war in 30%, and tariffs in 29%.

Five of the six largest manufacturing industries saw growth in August: transportation equipment, petroleum and coal products, machinery, computer and electronic products, and food, beverage and tobacco products.

The New Orders Index rose for the eighth consecutive month, registering 53.7%—a drop of 3 percentage points from July’s 56.7%. The Production Index came in at 58.3%, slightly lower by 0.2 percentage point compared to July’s 58.5%. The Prices Index stayed in expansion territory at 71.1%, unchanged from the prior month. The Backlog of Orders Index fell to 51.8%, down 3.2 percentage points from July’s 55%. The Employment Index slipped to 51.2%, a 1.6-percentage-point decrease from July’s 52.8%, with the sector adding 5,000 jobs in July.

The Supplier Deliveries Index pointed to slower performance for the ninth month in a row, following a single month in faster territory. It registered 59.3%, up 0.4 percentage point from July’s 58.9%. This is the only ISM PMI Report index where a reading above 50% denotes slower deliveries. The Inventories Index stood at 50.6%, down 0.6 percentage point from July’s 51.2%. The Customers Inventories Index climbed to 42.8%, a 2.1-percentage-point increase from the 40.7% recorded in July. The New Export Orders Index edged up 0.2 percentage point to 53.2%, compared to 53% the previous month. The Imports Index fell to 52.5%, a 3.2-percentage-point decline from July’s 55.7%.

Among ISM’s four demand indicators, three—New Orders, Backlog of Orders, and New Export Orders—remained in expansion, while the Customers Inventories Index stayed in too low territory, contracting at a faster pace. A too low reading on the Customers Inventories Index is typically viewed as a positive sign for future production.

Spence noted that August manufacturing activity stayed in expansion, though it lost ground in several key metrics, particularly New Orders, Backlog, and Imports. Of the five subindexes feeding into the PMI, only Supplier Deliveries accelerated compared to the prior month, signaling a continued slowdown in the supply chain.

Numerous respondents pointed to tariffs, inflation, and supply chain disruptions as drags on their operations. One respondent from the chemical products industry lamented that the economy was interfering with otherwise strong business, citing price escalations from tariffs and the Strait of Hormuz conflict as threats to sales and customer purchasing power. A respondent in the computer and electronic products sector described a fresh supply chain crisis, more severe and complex than the one seen during and after COVID-19, driven by AI infrastructure demands and global market volatility tied to the Middle East war and shifting trade regulations. The steel industry has also felt the impact, most recently from 50% tariffs imposed by Canada that mirrored new U.S. tariffs.

Spence expressed less optimism about this month’s results compared to last month’s. She highlighted that this was the first time she had observed a drop exceeding three points in three significant areas. While demand sentiment remains broadly positive, it has weakened, and she voiced uncertainty about customer behavior, indicating she is beginning to see warning signs.

Source link